Document rek4Vd24vR9yr37z3V5LwQ8jV

BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE May 2000 - October 2005 Click on Study Title to View Report PFOA Perfluorooctanoate Page 1, 2 1. "Ammonium Perfluorooctanoate: Age Effect on the PFOA Plasma Concentration in Post-Weaning Rats Following Oral Gavage," Paul M. Hinderliter (DuPont), DuPont -15302, December 2, 2004. 2. John A. Moore, D.V.M., DABT (Hollyhouse, Inc.), Comments to the PFOA Re view Panel regarding Points of Departure for PFOA Risk Assessment, February 10, 2005. 3. Butenhoff, J.L., et al., "Characterization of Risk for General Population Exposure to Perfluorooctanoate," Regulatory Toxicology and Pharmacology 39 (2004) 363-380, April 16, 2004. 4. Geary Olsen and Larry Zobel (3M), Comments of the 3M Company to the EPA Sci ence Advisory Board PFOA Review Panel, February 10, 2005. 5. Joseph V. Rodricks, Ph.D. (Environ Corp.), Comments to the PFOA Review Panel, February 11, 2005. 6. John L. Butenhoff, Ph.D., Geary Olsen, DVM, Ph.D., and Larry Zobel, M.D., Ph.D., "Additional Comments of the 3M Company to the EPA Science Advisory Board PFOA Review Panel," April 18, 2005. 7. Larry Zobel, M.D., M.P.H. (3M), Letter commenting on PFOA Review Panel's June 27, 2005 draft report, June 29, 2005. 8. Larry Zobel, M.D., M.P.H. (3M), Letter submitting Pathology Working Group Re port on Mammary Tumors in Chronic Study of PFOA, June 27, 2005. 9. Hardisty, J.F., Experimental Pathology Laboratories, Inc., "Pathology Peer Review and Pathology Working Group Review of Mammary Glands from a Chronic Feeding Study in Rats with PFOA," EPL Project No. 129-060, June 17, 2005. BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE May 2000 - October 2005 C lick on Study Title to V iew R eport PFOA Perfluorooctanoate Page 1 10. "Two-Year Toxicity/Carcinogenicity Study of Fluorochemical FC-143 [PFOA] in Rats," Review letter from Greg Sykes (Haskell Laboratory for Toxicology and Industrial Medicine) to Charles Reinhardt, October 29, 1987. 11. "Pathology Peer Review Report: 26-Week Capsule Toxicity Study with Ammo nium Perfluorooctanoate (APFO) in Cynomolgus Monkeys," Nancy A. Gillett (Sierra Biomedical), Covance Study No. 6329-231, February 3, 2000. 12. "H18636: Slide Review of pancreas lesions from DuPont APFO Study," E.E. McConnell and J.R. Foster, Study No. HN-18636, November 28, 2001. 13. "Review of proliferative lesions of the exocrine pancreas in two chronic studies in rat with ammonium perfluorooctanoate," S.R. Frame and E.E. McConnell, DuPont-13788, October 16, 2003. 14. "FC-143: Two Year Oral Toxicity-Oncogenicity Study in Rats Peer Review of Ovaries," Peter C. Mann (Experimental Pathology Laboratories, Inc.) and Steven R. Frame (DuPont, Haske Laboratory for Health and Environmental Science), DuPont-15261, June 25, 2004.